TTX’s Advanced Manufacturing Facility

Tetratherix has developed a biostealth fluid matrix that evolves regenerative medicine

Our mission is to use the Tetramatrix™ platform technology to help treat 10 million patients by 2035 by developing therapies, solutions and products that enable the future of healthcare delivery
10,000,000
People
Global
Reach
10
Years (By 2035)

Tetramatrix offers a mechanism of action which is evolving biomaterial science